Meloxicam and Nolvadex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meloxicam (meloxicam) and Nolvadex (tamoxifen citrate). Common drug interactions include oedema peripheral among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Meloxicam and Nolvadex. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,016 Meloxicam users. Check the latest studies of Meloxicam.

What is Nolvadex?

Nolvadex has active ingredients of tamoxifen citrate. It is often used in breast cancer. eHealthMe is studying from 5,506 Nolvadex users. Check the latest studies of Nolvadex.

On Jul, 08, 2026

28 people who take Meloxicam and Nolvadex together, and have interactions are studied.

Meloxicam and Nolvadex drug interactions.

What are the common drug interactions of Meloxicam and Nolvadex, by gender? *:

female:

Oedema peripheral (superficial swelling)
Pain in extremity
Anxiety
Back pain
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Cardiac failure congestive
Cardiomegaly (increased size of heart than normal)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

male:

Abdominal distension
Abdominal pain
Asthenia (weakness)
Asthma
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrioventricular block first degree (heart block first degree)
Back pain
Balance disorder
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Bone loss

What are the common drug interactions of Meloxicam and Nolvadex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Alopecia (absence of hair from areas of the body)
Poor venous access

60+:

Dyspnoea (difficult or laboured respiration)
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Dehydration (dryness resulting from the removal of water)
Fatigue (feeling of tiredness)
Hot flush (sudden feelings of heat)
Mitral valve incompetence (inefficient heart valve)
Mitral valve prolapse (heart's mitral valve doesn't work well)
Oedema peripheral (superficial swelling)
Pain in extremity
Tricuspid valve incompetence (inefficient heart valve)

What are the existing conditions these people have? *

Metastatic Neoplasm (spreadable cancer tumour): 16 people, 57.14%
Breast Cancer Metastatic: 16 people, 57.14%
Hypersensitivity: 12 people, 42.86%
Diabetes: 12 people, 42.86%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 2 people, 7.14%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 7.14%
Metastases To Bone (cancer spreads to bone): 2 people, 7.14%
Gastric Ulcer (stomach ulcer): 2 people, 7.14%
Breast Cancer Female: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam and Nolvadex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously